Betty Z. Benedict Endowment of $2 Million to SCTC:

SCTC - Scleroderma Clinical Trials Consortium

Our Misson

The SCTC is an international consortium representing the vast majority of researchers and clinicians who have particular interest and expertise in the care of, and research in, scleroderma (systemic sclerosis).  The goal of the SCTC is to conduct, sponsor, or facilitate clinical research projects that lead to advances in the management, treatment, and outcomes of patients with scleroderma.  The SCTC aims to represent the views and interests of its membership regarding the performance of clinical research in scleroderma.  The SCTC seeks to ensure that research in scleroderma adheres to high standards for design, conduct, and reporting of results.  The SCTC is particularly focused on improving and developing outcome measures for clinical trials and observational studies, participating in the design and conduct of clinical trials and observational studies, and helping to improve the efficiency of clinical trials.  The SCTC strongly encourages international collaboration, inclusiveness in research groups, and involvement of trainees and junior faculty in all its activities.

Image

Betty Z. Benedict Grant for Proposals to Advance the Science of Outcome Measures in Systemic Sclerosis

Congratulations to Mandana Nikpour, Murray Baron and Laura Ross who have been awarded $100,000 over 2 years for their study on the Development and Validation of a Disease Activity Index in Systemic Sclerosis.

The new Request for Applications will be released in March 2020.

Congratulations to the 2019 SCTC Working Group Grant Awardees

Recipients of the 6th Systemic Sclerosis World Congress SCTC-WSF-FWSF Travel Awards Announced

Find out about the SCTC Benedict Visiting Fellowship Programme

Get Involved with SCTC

6th Systemic Sclerosis World Congress

5th - 7th March 2020, Prague

Become a Member of SCTC

Please join us. There are two types of Membership to choose from:

>> Full member

>> Provisional Member

Donate to SCTC

Donate today to help SCTC and its mission to support research to establish standard outcome measures for clinical treatment trials so that results can be compared over time and over different patient groups.




Pay Membership Fees

If you are a newly accepted member of the SCTC, please select Initial Fee at $250.00 USD.
If you are a returning member of the SCTC, please select the option of Annual Fee at $200.00 USD.
If your institution is unable to use PayPal, please contact admin@sclerodermaclinicaltrials.org.

Membership Fees



© 2020 Scleroderma Clinical Trials Consortium. Designed By Kangablu Ltd